期刊文献+

培美曲塞联合顺铂同步放疗局部晚期非小细胞肺癌疗效观察 被引量:10

Curative effect observation of pemetrexed combined with cisplatin and synchronous three-dimensional conformal radiotherapy for locally advanced non-small cell lung cancer
下载PDF
导出
摘要 目的:观察培美曲塞联合顺铂同步三维适形放疗(3D‐CRT )治疗局部晚期非小细胞肺癌(NSCLC )的疗效与安全性。方法40例局部晚期NSCLC患者入组,其中39例完成放化疗,培美曲塞500 mg/m2,d1,静脉滴注,顺铂25 mg/m2,d1~3,静脉滴注;21 d为1个周期,共3个周期,同步放化疗后巩固2个周期;化疗第1天行3D‐CRT ,DT 66 Gy/33 f/45 d。靶区采用累积野照射,V20<35%。结果39例中CR3例,PR27例,SD6例,PD3例,总有效率(RR)为76.9%,1、2年总生存率和局部控制率分别为75.2、38.5和85%。不良反应主要表现为血液学毒性,出现Ⅲ/Ⅳ度白细胞减少、贫血和血小板减少的患者分别为9、3和2例。结论3D‐CRT治疗局部晚期NSCLC近期及远期疗效均较好,不良反应低,为局部晚期NSCLC的有效方法。 Objective To observe the curative effect and security of pemetrexed combined with cisplatin and synchronous three‐dimensional conformal radiotherapy (3D‐CRT)for locally advancednon‐small cell lung cancer (NSCLC).Methods There were 40 cases of locally adanced NSCLC patients ,among which 39 patients underwent chemoradiation ,pemetrexed 500 mg/m2 , d1 ,intravenous drip ,Cisplatin 25 mg/m2 ,d1~3 ,intravenous drip ;21 d for a cycle ,a total of three cycles ,the chemoradiation consolidate after 2 cycle .The first day of chemotherapy is 3 d‐CRT ,DT 66 Gy /33 f /45 d .Accumulated irradiation for target area was used ,V20〈35%.Results 3 of the 39 cases were CR ,27 cases were PR ,6 cases were SD ,3 cases were PD ,the total effective rate (RR) was 76 .9% .the 1 and 2 years overall survival rate and local control was 75.2 ,38.5 and 85% .The toxic side‐effect of mainly manifests hematology toxicity ,and the cases with Ⅲ /Ⅳ degree leukopenia ,anemia ,and thrombocytopenia were 9 ,3 and 2 cases .Conclusion The treatment of pemetrexed combined with cisplatin and synchronous 3D‐CRT for locally advanced NSCLC had near‐term and the long‐term effect ,low toxicity ,and it was an effective method in treating NSCLC .
出处 《滨州医学院学报》 2014年第5期331-333,共3页 Journal of Binzhou Medical University
基金 滨州医学院科技计划项目(BY2011KJ034)
关键词 非小细胞肺癌 培美曲塞 顺铂 三维适行放疗 non-small cell lung cancer, pemetrexed,cisplatin,three-dimensional conformal radiotherapy
  • 相关文献

参考文献12

  • 1Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radia- tion therapy for inoperable early stage lung cancer[J]. JAMA,2010,303(11):1070-1076.
  • 2朱广迎,申戈.局部晚期非小细胞肺癌同步放化疗规范[J].癌症进展,2009,7(4):370-378. 被引量:14
  • 3Spranger J, Krobe A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes, resuhs of the prospective populationbased European prospective investigation into Cancer and Nutrition (EPIC) Possdam Study[J]. Diabetes, 2003,52 (3) ,812-817.
  • 4孙建湘,莫清华,周隆军,廖彬生.三维适形加量放疗联合化疗治疗非小细胞肺癌的临床观察[J].中华肿瘤防治杂志,2007,14(24):1889-1890. 被引量:11
  • 5Belani CP, Choy H, Bonomi P, et al. Combined chemoradiothera- py regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: A randomized phase Ⅱ locally ad- vanced multi-modality protocol[J]. J Clin Oncol, 1999,23 (25) : 5883-5891.
  • 6Seiwert TY, Connell PP, Mauer AM, et al. A phase I study of pemetrexed, carboplatin, and conncurrent radiotherapy in pa- tients with lacally advanced or metastatic non-small cell lung or esophageal cancer[J]. Clin Cancer Rer, 2007,13 (2 pt 1) : 515- 522.
  • 7王小震,王绿化,吕纪马,姬巍,周宗玫,梁军,欧广飞,张红星,冯勤付,殷蔚伯.Ⅲ期非小细胞肺癌放疗加紫杉醇卡铂同步化疗的临床试验结果[J].中华放射肿瘤学杂志,2006,15(4):270-274. 被引量:36
  • 8李付海,石安辉,朱广迎.局部晚期非小细胞肺癌同步放化疗进展[J].中国肿瘤,2009,18(10):831-834. 被引量:11
  • 9Curran WJ,Scott CB,Langer CJ,et al. Long term benefit is ob- serve dina phase Ⅲ comparison of sequential vs concurrent che- moradiation for patients with unresected stage Ⅲ NSCLC: RTOG9410[J]. Proc Am Soc Clin Oncol,2003,22(5) :621-627.
  • 10Cater DL, Kellr AM, Tolley RC, et al. A randomized phase Ⅲ trial of combined paclitaxel, carboplatin, and tad iation therapy follow by either weekly paelitaxel obserbation in patients with stage Ⅲ non-small cell lung cancer[J]. Proc Am Soc Clin On- col,2004,8(10) :70-76.

二级参考文献66

共引文献100

同被引文献93

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部